HLA-G: At the Interface of Maternal–Fetal Tolerance

Publication date: Available online 6 March 2017
Source:Trends in Immunology
Author(s): Leonardo M.R. Ferreira, Torsten B. Meissner, Tamara Tilburgs, Jack L. Strominger
During pregnancy, semiallogeneic fetal extravillous trophoblasts (EVT) invade the uterine mucosa without being rejected by the maternal immune system. Several mechanisms were initially proposed by Peter Medawar half a century ago to explain this apparent violation of the laws of transplantation. Then, three decades ago, an unusual human leukocyte antigen (HLA) molecule was identified: HLA-G. Uniquely expressed in EVT, HLA-G has since become the center of the present understanding of fetus-induced immune tolerance. Despite slow progress in the field, the last few years have seen an explosion in our knowledge of HLA-G biology. Here, we critically review new insights into the mechanisms controlling the expression and function of HLA-G at the maternal–fetal interface, and discuss their relevance for fetal tolerance.



http://ift.tt/2mPg9wi